1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Allergy Blood Tests - Pipeline Review, 2015

Allergy Blood Tests - Pipeline Review, 2015

  • May 2015
  • -
  • Global Data
  • -
  • 32 pages

Allergy Blood Tests - Pipeline Review, 2015

Summary

GlobalData's Medical Devices sector report, “Allergy Blood Tests - Pipeline Review, 2015" provides an overview of Allergy Blood Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Allergy Blood Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Allergy Blood Tests products under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Allergy Blood Tests and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Allergy Blood Tests under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table Of Contents

Allergy Blood Tests - Pipeline Review, 2015
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 4
2 Introduction 5
2.1 Allergy Blood Tests Overview 5
3 Products under Development 6
3.1 Allergy Blood Tests - Pipeline Products by Stage of Development 6
3.2 Allergy Blood Tests - Pipeline Products by Territory 7
3.3 Allergy Blood Tests - Pipeline Products by Regulatory Path 8
3.4 Allergy Blood Tests - Pipeline Products by Estimated Approval Date 9
4 Allergy Blood Tests - Pipeline Products under Development by Companies 10
4.1 Allergy Blood Tests Companies - Pipeline Products by Stage of Development 10
4.2 Allergy Blood Tests - Pipeline Products by Stage of Development 11
5 Allergy Blood Tests Companies and Product Overview 12
5.1 Abionic SA Company Overview 12
5.1.1 Abionic SA Pipeline Products and Ongoing Clinical Trials Overview 12
5.2 Amerimmune Company Overview 13
5.2.1 Amerimmune Pipeline Products and Ongoing Clinical Trials Overview 13
5.3 Atomo Diagnostics Pty Limited Company Overview 15
5.3.1 Atomo Diagnostics Pty Limited Pipeline Products and Ongoing Clinical Trials Overview 15
5.4 AXO Science S.A.S. Company Overview 16
5.4.1 AXO Science S.A.S. Pipeline Products and Ongoing Clinical Trials Overview 16
5.5 Bioftalmik Applied Research Company Overview 18
5.5.1 Bioftalmik Applied Research Pipeline Products and Ongoing Clinical Trials Overview 18
5.6 Children's Hospital Boston Company Overview 19
5.6.1 Children's Hospital Boston Pipeline Products and Ongoing Clinical Trials Overview 19
5.7 Cincinnati Children's Hospital Medical Center Company Overview 20
5.7.1 Cincinnati Children's Hospital Medical Center Pipeline Products and Ongoing Clinical Trials Overview 20
5.8 Cytognos, S.L. Company Overview 21
5.8.1 Cytognos, S.L. Pipeline Products and Ongoing Clinical Trials Overview 21
5.9 Hycor Biomedical Inc. Company Overview 22
5.9.1 Hycor Biomedical Inc. Pipeline Products and Ongoing Clinical Trials Overview 22
5.10 Sistemas Genomicos, S.L. Company Overview 24
5.10.1 Sistemas Genomicos, S.L. Pipeline Products and Ongoing Clinical Trials Overview 24
5.11 St. Jude Children's Research Hospital, Inc. Company Overview 25
5.11.1 St. Jude Children's Research Hospital, Inc. Pipeline Products and Ongoing Clinical Trials Overview 25
5.12 The Binding Site Group Ltd. Company Overview 26
5.12.1 The Binding Site Group Ltd. Pipeline Products and Ongoing Clinical Trials Overview 26
5.13 The University of Queensland Company Overview 27
5.13.1 The University of Queensland Pipeline Products and Ongoing Clinical Trials Overview 27
6 Allergy Blood Tests- Recent Developments 28
7 Appendix 30
7.1 Methodology 30
7.2 About GlobalData 32
7.3 Contact Us 32
7.4 Disclaimer 32

1.1 List of Tables
Table 1: Allergy Blood Tests - Pipeline Products by Stage of Development 6
Table 2: Allergy Blood Tests - Pipeline Products by Territory 7
Table 3: Allergy Blood Tests - Pipeline Products by Regulatory Path 8
Table 4: Allergy Blood Tests - Pipeline Products by Estimated Approval Date 9
Table 5: Allergy Blood Tests Companies - Pipeline Products by Stage of Development 10
Table 6: Allergy Blood Tests - Pipeline Products by Stage of Development 11
Table 7: Abionic SA Pipeline Products and Ongoing Clinical Trials Overview 12
Table 8: abioKIT - Product Status 12
Table 9: abioKIT - Product Description 12
Table 10: Amerimmune Pipeline Products and Ongoing Clinical Trials Overview 13
Table 11: Basophile Panel - Product Status 13
Table 12: Basophile Panel - Product Description 13
Table 13: CD69 and IgE Receptor Expression Assay - Product Status 14
Table 14: CD69 and IgE Receptor Expression Assay - Product Description 14
Table 15: Atomo Diagnostics Pty Limited Pipeline Products and Ongoing Clinical Trials Overview 15
Table 16: AtomoRapid - Allergy - Product Status 15
Table 17: AtomoRapid - Allergy - Product Description 15
Table 18: AXO Science S.A.S. Pipeline Products and Ongoing Clinical Trials Overview 16
Table 19: Companion Diagnostic Test - Allergy - Product Status 16
Table 20: Companion Diagnostic Test - Allergy - Product Description 16
Table 21: Diagnostic Test - Allergy - Product Status 17
Table 22: Diagnostic Test - Allergy - Product Description 17
Table 23: Bioftalmik Applied Research Pipeline Products and Ongoing Clinical Trials Overview 18
Table 24: Diagnostic Test - Pediatric Occular Allergy - Product Status 18
Table 25: Diagnostic Test - Pediatric Occular Allergy - Product Description 18
Table 26: Children's Hospital Boston Pipeline Products and Ongoing Clinical Trials Overview 19
Table 27: Biomarker Assay - Allergy - Product Status 19
Table 28: Biomarker Assay - Allergy - Product Description 19
Table 29: Cincinnati Children's Hospital Medical Center Pipeline Products and Ongoing Clinical Trials Overview 20
Table 30: Genetic Marker Diagnostic Test - Food Allergy - Product Status 20
Table 31: Genetic Marker Diagnostic Test - Food Allergy - Product Description 20
Table 32: Cytognos, S.L. Pipeline Products and Ongoing Clinical Trials Overview 21
Table 33: Diagnosis Flow Cytometry Kit - Type 1 Hypersensitivity - Product Status 21
Table 34: Diagnosis Flow Cytometry Kit - Type 1 Hypersensitivity - Product Description 21
Table 35: Hycor Biomedical Inc. Pipeline Products and Ongoing Clinical Trials Overview 22
Table 36: HYTEC 288 PLUS - Eosinophil Cationic Protein Test - Product Status 22
Table 37: HYTEC 288 PLUS - Eosinophil Cationic Protein Test - Product Description 23
Table 38: HYTEC 288 PLUS - Tryptase Test - Product Status 23
Table 39: HYTEC 288 PLUS - Tryptase Test - Product Description 23
Table 40: Sistemas Genomicos, S.L. Pipeline Products and Ongoing Clinical Trials Overview 24
Table 41: Inmutest - Product Status 24
Table 42: Inmutest - Product Description 24
Table 43: St. Jude Children's Research Hospital, Inc. Pipeline Products and Ongoing Clinical Trials Overview 25
Table 44: Diagnostic Assay - Allergic Disease - Product Status 25
Table 45: Diagnostic Assay - Allergic Disease - Product Description 25
Table 46: The Binding Site Group Ltd. Pipeline Products and Ongoing Clinical Trials Overview 26
Table 47: SPA PLUS - IgE Assay - Product Status 26
Table 48: SPA PLUS - IgE Assay - Product Description 26
Table 49: The University of Queensland Pipeline Products and Ongoing Clinical Trials Overview 27
Table 50: Diagnostic Assay - Allergy - Product Status 27
Table 51: Diagnostic Assay - Allergy - Product Description 27
Table 52: Glossary 31

1.2 List of Figures
Figure 1: Allergy Blood Tests - Pipeline Products by Stage of Development 6
Figure 2: Allergy Blood Tests - Pipeline Products by Territory 7
Figure 3: Allergy Blood Tests - Pipeline Products by Regulatory Path 8
Figure 4: Allergy Blood Tests - Pipeline Products by Estimated Approval Date 9

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.